R&D
Our Research and Development department is specializing in development of technologically difficult manufacturing processes for high value active pharmaceutical ingredients (APIs).
Many of our products are used in hospitals for the treatment of life-threatening infectious diseases. Xellia also develops and manufactures dosage form pharmaceuticals (mainly injectables) on behalf of industry customers.
Our staff is highly skilled (more than 1/3 having a PhD) with an average of more than ten years’ experience in the pharmaceutical industry. Competencies include all aspects of classical and modern biotechnology, including strain development (classical mutagenesis and recombinant DNA techniques), fermentation and cell cultivation, separation and purification, final handling and process scale-up. We have broad experience in developing organic synthesis strategies and processes for synthetic and semi-synthetic APIs and have established a broad, international R&D network.
